Interval to Recurrence Affects Survival in Recurrent Head and Neck Squamous Cell Carcinoma
The selection of treatment for patients with recurrent head and neck squamous cell carcinoma should consider the timing of recurrence, the initial treatment regimen, and the strategy for changing salvage therapy depending on the recurrence status.
Authors
- Tomomi Manako (ORCID: https://orcid.org/0009-0007-3359-6831)
- Ryunosuke Kogo (ORCID: https://orcid.org/0000-0002-7030-7302)
- Mioko Matsuo (ORCID: https://orcid.org/0000-0002-9158-1298)
- Takashi Nakagawa (ORCID: https://orcid.org/0000-0003-3179-6462)
- Masanobu Sato (ORCID: https://orcid.org/0000-0001-7108-0376)
- Kazuki Hashimoto (ORCID: https://orcid.org/0000-0002-8324-2202)
Institutions
- Kyushu University (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21873/cdp.10378
- Citations
- 3
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.74